Abstract: Worldwide, TB is one of the top 10 causes of death. In 2017, TB caused an estimated 1.3 million deaths among HIV-negative people and there were an additional 300 000 deaths among HIV-positive people. Globally, the best estimate is that 10.0 million people developed TB disease in 2017. Drug-resistant TB continues to be a public health crisis. Worldwide in 2017, 558 000 people developed TB that was resistant to rifampicin (RR-TB) and 82% had multidrug-resistant TB(MDR-TB).India, China and the Russian Federation accounted for almost half of the world’s cases of MDR/RR-TB. Although the disease burden caused by TB is falling globally in all WHO regions, in most countries, it is not fast enough to reach the first (2020) milestones of the End TB Strategy. Diagnosis and successful treatment of people with TB averts millions of deaths each year (an estimated 54 million over the period 2000-2017), but there are still large and persistent gaps in detection and treatment. The latest treatment outcome data for new casess show a global treatment success rate of 82% in 2016. The End TB Strategy targets set for 2035 cannot be met without intensified research and development.

Key words: WHO, Tuberculosis, MDR-TB, Report